The 4-Item Negative Symptom Assessment (NSA-4) Instrument: A Simple Tool for Evaluating Negative Symptoms in Schizophrenia Following Brief Training

| July 27, 2010 | 0 Comments

by Larry Alphs, MD, PhD; Robert Morlock, PhD; Cheryl Coon, PhD; Arjen van Willigenburg, MS; and John Panagides, PhD
Dr. Alphs is from Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, New Jersey (at the time this research was conducted, Dr. Alphs was employed at Pfizer Global R&D, Ann Arbor, Michigan); Dr. Morlock is from Biogen Idec, La Jolla, California (at the time this research was conducted Dr. Morlock was employed at Pfizer Global R&D, Ann Arbor, Michigan); Dr. Coon is from RTI Health Solutions, Research Triangle Park, North Carolina; Mr. van Willigenburg is from Complete Healthcare Communications Europe, The Netherlands (at the time this research was conducted Mr. van Willigenburg was an employee at Schering Plough Corp, Summit, New Jersey); and Dr. Panagides is from Schering Corp., a division of Merck and Co., Summit, New Jersey.

Psychiatry (Edgemont) 2010;7(7):26–32

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , ,

Category: Drug Development, Original Research, Past Articles, Psychiatry, Schizophrenia, Trial Methodology

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.